Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals Inc. buy tamam

Start price
€110.02
15.06.17 / 50%
Target price
€270.00
04.11.21
Performance (%)
52.01%
End price
€167.24
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €167.24. With a performance of 52.01% the BUY prediction by tamam was a big success. tamam has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Vertex Pharmaceuticals Inc. 0.324% 0.324% 26.779% 106.885%
iShares Core DAX® 2.594% -1.158% 14.782% 16.813%
iShares Nasdaq 100 3.553% -1.727% 43.265% 44.227%
iShares Nikkei 225® 0.687% -8.354% 18.454% 1.361%
iShares S&P 500 2.209% -0.942% 31.361% 42.812%

Comments by tamam for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 52.01%
Target price 176.792
Change
Ends at 04.11.21

tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu

tamam stimmt am 15.06.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 196.00$ zu.

Prediction Buy
Perf. (%) 52.01%
Target price 210.000
Change
Ends at 04.11.21

Kursziel geändert auf 210,0

Prediction Buy
Perf. (%) 52.01%
Target price 240.000
Change
Ends at 04.11.21

Kursziel geändert auf 240,0

Prediction Buy
Perf. (%) 52.01%
Target price 250.000
Change
Ends at 04.11.21

Kursziel geändert auf 250,0

Prediction Buy
Perf. (%) 52.01%
Target price 270.000
Change
Ends at 04.11.21

Kursziel geändert auf 270,0

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 52.01%
Target price 270.000
Change
Ends at 04.11.21

Die von tamam gewählte maximale Laufzeit wurde überschritten

Stopped prediction by tamam for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€104.92
21.09.15
€135.30
21.03.16
-29.06%
21.03.16